title: Long-acting injectable antipsychotics. Review and recent developments.
abstract: Long-acting injectable antipsychotics, also known as `depots`, were developed in the late 1960s as an attempt to improve compliance and long-term management of schizophrenia.  Despite their availability for over 30 years, guidelines for their use and data on patients for whom long-acting injectable antipsychotics are most indicated are sparse and vary considerably. A review of the perceived advantages and disadvantages of using long-acting injectable antipsychotics is provided in this article, as well as a review of the literature to update clinicians on the current advances of this therapeutic option to optimize compliance and long-term management of chronic schizophrenia.
authors.affiliation: Lecturer in Clinical Pharmacy, School of Pharmacy, The University of Auckland, Room 40018, Lower Ground Floor, Building 504, 85 Park Road, Grafton, Auckland, New Zealand. Tel. +64 9 373 7599 Ext. 82225.  Fax. +69 9 367 7192.  E-mail: m.zolezzi@auckland.ac.nz.
authors.forename: Monica
authors.initials: M
authors.lastname: Zolezzi